Sign in Subscribe
Antineoplastic agents

NHS Approves Groundbreaking At-Home Treatment for Advanced Prostate Cancer

Strategic Insights

— 1 min read

Thousands of men in the UK with advanced prostate cancer are set to benefit from a groundbreaking at-home treatment, Relugolix, which has been approved by the National Institute for Health and Care Excellence (NICE) for use on the NHS. The pill, known by its brand name Orgovyx, is a major advance in treating the disease, potentially helping 40,000 men, and can be taken at home, sparing men from grueling hospital trips.

Key Takeaways:

  • Relugolix, an androgen therapy, works by blocking the production of testosterone, which prostate cancer needs to grow.
  • The treatment is expected to be available to patients on the NHS within three months of NICE's final draft guidance being published.
  • The recommendation by NICE opens the door for the Scottish Medicines Consortium to consider if Relugolix should also be available for routine use in Scotland.
  • Prostate Cancer UK hailed the decision as "fantastic news" for patients, citing its potential to be a "game-changer" in terms of men's experience of treatment.
  • Trials have shown that Relugolix also lowers the risk of heart attacks and other cardiovascular problems linked to testosterone therapies.
  • Prostate cancer is the most common cancer among men in the UK, with over 12,000 deaths annually.
  • In Scotland, more than 3,800 men are diagnosed with prostate cancer each year, and over 1,000 die from the disease annually.
  • Patients suffering from advanced prostate cancers are usually offered hormone therapies, surgery, or radiotherapy.
  • Relugolix has been found to be better at reducing testosterone to levels that stop cancer growth in the longer term than other alternatives.

Statistics:

  • Over 40,000 men are expected to benefit from Relugolix treatment in the UK.
  • 112,000 men are diagnosed with prostate cancer annually in the UK.
  • Over 12,000 men die from prostate cancer in the UK each year.
  • In Scotland, more than 3,800 men are diagnosed with prostate cancer each year, and over 1,000 die from the disease annually.
  • 32,000 men are currently living with or after prostate cancer in Scotland.

Sources:

  • "NHS approves first at-home treatment for prostate cancer" by The Telegraph
  • "Relugolix: the new at-home pill approved for prostate cancer treatment" by Prostate Cancer UK
  • "NICE approves Relugolix for use on NHS" by National Institute for Health and Care Excellence

Read more